About DTA


Transforming global healthcare by advancing digital therapeutics to improve clinical and health economic outcomes.


Broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics with patients, clinicians, payors, policymakers through education, advocacy, and cross-industry collaboration.

Who We Are

Founded in 2017, the Digital Therapeutics Alliance is a 501(c)(6) non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. As the leading international organization on digital therapeutic thought leadership and education, the Digital Therapeutics Alliance provides patients, clinicians, payors, and policymakers with the necessary tools to evaluate and utilize DTx products.

Learn about our Members

What We Do

DTA brings together leading organizations through worldwide collaboration to improve clinical and health economic outcomes by advancing the use of high quality, evidence-based digital therapeutics by patients, clinicians, payors, and policymakers.

Learn more about DTA’s current initiatives and milestones.

Advancing DTx
Therapy Progression Graphic

Board of Directors

Everett Crosland
Chief Commercial Officer
Cognito Therapeutics
Peter Hames
Co-Founder and CEO
Big Health
Anand Iyer
Chief Strategy Officer
Eddie Martucci
Chief Executive Officer
Akili Interactive
Owen McCarthy
Debra Reisenthel
Founding President and CEO
Julia Strandberg
Chief Commercial Officer
Pear Therapeutics
Andy Molnar
Chief Executive Officer
Digital Therapeutics Alliance

DTA Team

Megan Coder
Chief Policy Officer
Hannah Fairman
Engagement Manager
Jessica Hauflaire
Chief Operating Officer
Alexis Klosinski
Executive Assistant
Emilie Lopes-Fernandes
Relationship Manager
Andy Molnar
Chief Executive Officer
Hazel Nugent
Director of Business Development
Liz Sherman
Office Manager

Join the DTA Community

Connect Now
Copyright © 2022 Digital Therapeutics Alliance™